CSL Limited (OTCMKTS:CSLLY – Get Free Report) shares hit a new 52-week high during trading on Tuesday . The company traded as high as $106.82 and last traded at $103.40, with a volume of 18469 shares trading hands. The stock had previously closed at $103.09.
CSL Price Performance
The business’s 50-day moving average price is $97.53 and its 200 day moving average price is $94.73.
CSL Company Profile
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Articles
- Five stocks we like better than CSL
- The 3 Best Fintech Stocks to Buy Now
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Stock Analyst Ratings and Canadian Analyst Ratings
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Ride Out The Recession With These Dividend Kings
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.
